Skip to main content
Fig. 3 | Molecular Medicine

Fig. 3

From: Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients

Fig. 3

A The mRNA expression levels of LAMB3, FN1, KRT17, KRT19, and ANXA1 as assessed by RNA-seq between PCs and controls (including paracancer or normal pancreas). B The Kaplan–Meier DFS curves for PC patients assigned to high and low expression groups of LAMB3, FN1, KRT17, KRT19, and ANXA1 based on the expression level, respectively. The median was selected as the cutoff value for high or low groups. The blue lines are the low expression groups and the red lines are the high expression groups. C The Kaplan–Meier OS curves for PC patients assigned to high and low expression groups of LAMB3, FN1, KRT17, KRT19, and ANXA1 based on the expression level, respectively. The median was selected as the cutoff value for high or low groups. The blue lines are the low expression groups and the red lines are the high expression groups

Back to article page